Opus Genetics revises Cohort 1 data presentation
The company corrected a logMAR-to-ETDRS translation error in its data presentation and said low-dose Cohort 1 showed functional and structural gains with no serious adverse events.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.